Fentanyl Tops Drug Shortage List For Anesthesiologists
Additional data released in the American Society of Anesthesiologist's survey of more than 3,000 anesthesiologists reveals that more than two thirds of respondents are currently experiencing a shortage of fentanyl.
The full survey, released Tuesday, shows that 66 percent of anesthesiologists are seeing a shortage in fentanyl, followed by thiopental (40 percent), succinylcholine (20 percent), propofol (19 percent) and pancuronium (15 percent). Anesthesiologists also noted that as a result of these shortages, patients experienced post-operative nausea and vomiting (66 percent) and longer OR and recovery times (52 percent).
Initial survey data indicated that at least seven patient deaths had occurred as a result of the nationwide anesthesia drug shortage.
Related Articles on Anesthesia:Anesthesiologist Studies Survival Rate of Helicopter Transport Patients
Florida Gulf-to-Bay Anesthesiology Associates Partners With Private Equity Firm
Medicare ACOs Are Blooming (With or Without Anesthesiologists)
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Senate Introduces Companion Medicare RAC Reform Bill
- Drs. Brian Cole, Anthony Romeo of Midwest Orthopaedics at Rush Among Top Orthopedic Surgeons Contributing to Orthopedic Literature
- Spinal Elements Upgrades to 40,000-Square-Foot Headquarters
- UnitedHealth, Aetna, Cigna to Sit Out of California's Health Insurance Exchange
- Rhode Island Nixes "Confidential" Prices Between Payors, Providers